臨牀消化器内科 Vol.21 No.2(4-2-6)


特集名 膵管内乳頭粘液性腫瘍 (IPMT ; intraductal papillary-mucinous tumor)
題名 診 断 (2) 診断と鑑別 f. 分子生物学的検討
発刊年月 2006年 02月
著者 小林 規俊 横浜市立大学大学院医学研究科分子消化管内科学講座
著者 窪田 賢輔 横浜市立大学大学院医学研究科分子消化管内科学講座
著者 中島 淳 横浜市立大学大学院医学研究科分子消化管内科学講座
【 要旨 】 膵管内乳頭粘液性腫瘍 (intraductal papillrary-mucinous tumor ; IPMT) は,浸潤型膵管癌 (以下,膵癌) と異なり,進行が遅く,生物学的悪性度も低い腫瘍と考えられている.しかし,ひとたび浸潤癌になると予後は悪く膵癌と同様であると考えられており,膵癌との相違が臨床上重要である.IPMTの分子生物学的解明は未だ十分に進んでいるとはいえないが,いくつかの特徴的な点が明らかになってきた.今回IPMTの分子生物学的特徴について現在まで解明されている点を,膵癌と対比しながら説明する.
Theme IPMT ; Intraductal Papillary-Mucinous Tumor
Title Molecular-Biological Features of Intraductal Papillary-Mucinous Tumors
Author Noritoshi Kobayashi Gastroenterology Division, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine
Author Kensuke Kubota Gastroenterology Division, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine
Author Atsushi Nakajima Gastroenterology Division, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine
[ Summary ] Intraductal papillary-mucinous tumors (IPMTs) of the pancreas are characterized by slower growth compared with invasive ductal carcinomas of the pancreas (IDCs). However, some invasive IPMTs show a rapid progression and have a poor prognosis, similar to IDCs. The clinical features of IPMTs are sometimes similar to IDCs. The difference between the molecular-biological features of IPMTs and IDCs are very important factors for diagnosis. We will explain some molecular-biological features of IPMTs, in relation to genetic changes, clonality and mucin expression. K-ras codon 12 mutations are often detectable in the early stages of IPMTs. However, this mutation is also frequently seen without any relationship to pathological grade. The expression of p 53 protein or LOH of the p53 gene may be an indicator of the malignancy of IPMTs. These mutation patterns are similar to IDCs. Most IPMTs are polyclonal or oligoclonal in origin and different from IDCs with mucin expression patterns (MUC 1, MUC 2, MUC 5 AC). IPMTs and IDCs are clearly different entities in relation to their clinical and molecular-biological features.
戻る